N-[1-[(2S)-4-bromo-5-chloro-2-phenyl-3H-1-benzofuran-2-yl]ethyl]-N,2-dimethylpropane-2-sulfinamide
C21H25BrClNO2S — CID 156855615
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[1-[(2S)-4-bromo-5-chloro-2-phenyl-3H-1-benzofuran-2-yl]ethyl]-N,2-dimethylpropane-2-sulfinamide
N-[1-[(2S)-4-bromo-5-chloro-2-phenyl-3H-1-benzofuran-2-yl]ethyl]-N,2-dimethylpropane-2-sulfinamide (PubChem CID 156855615) has the molecular formula C21H25BrClNO2S and a molecular weight of 470.86 g/mol. Its IUPAC name is N-[1-[(2S)-4-bromo-5-chloro-2-phenyl-3H-1-benzofuran-2-yl]ethyl]-N,2-dimethylpropane-2-sulfinamide.
Molecular Properties
| Compound Name | N-[1-[(2S)-4-bromo-5-chloro-2-phenyl-3H-1-benzofuran-2-yl]ethyl]-N,2-dimethylpropane-2-sulfinamide |
|---|---|
| PubChem CID | 156855615 |
| Molecular Formula | C21H25BrClNO2S |
| Molecular Weight | 470.86 g/mol |
| Exact Mass | 469.05 |
| IUPAC Name | N-[1-[(2S)-4-bromo-5-chloro-2-phenyl-3H-1-benzofuran-2-yl]ethyl]-N,2-dimethylpropane-2-sulfinamide |
| SMILES | CC(N(C)S(=O)C(C)(C)C)[C@@]1(c2ccccc2)Cc2c(ccc(Cl)c2Br)O1 |
| InChI | InChI=1S/C21H25BrClNO2S/c1-14(24(5)27(25)20(2,3)4)21(15-9-7-6-8-10-15)13-16-18(26-21)12-11-17(23)19(16)22/h6-12,14H,13H2,1-5H3/t14?,21-,27?/m1/s1 |
| InChIKey | NYPYCAIMVBKVMH-OQXCJMHMSA-N |
| XLogP | 5.72 |
| TPSA | 29.54 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 470.86 |
| LogP ≤ 5 | 5.72 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 2 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156855615 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.